Olverembatinib Granted Breakthrough Therapy Designation for the Treatment of Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage…
ORYZON Announces the Voting Results of February 2025 Extraordinary General Shareholders’ Meeting
February 28, 2025 09:14 ET | Source: Oryzon Genomics, S.A. All resolutions…
ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders Meeting
January 27, 2025 09:31 ET | Source: Oryzon Genomics, S.A. Aimed at…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Reviva Announces Proposed Public Offering
December 16, 2024 17:18 ET | Source: Reviva Pharmaceuticals CUPERTINO, Calif., Dec.…
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ProQR…
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
WILMETTE, Ill., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq:…
Radiopharm Achieves Nasdaq Listing of American Depositary Shares
November 27, 2024 08:00 ET | Source: Radiopharm Theranostics Trading under ticker…